Article info
PDFCognition
Original research
CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers
- Correspondence to Professor Ashley Ian Bush, Florey Institute of Neuroscience and Mental Health, Parkville, VIC 3052, Australia; ashley.bush{at}florey.edu.au
Citation
CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers
Publication history
- Received July 26, 2022
- Accepted October 23, 2022
- First published November 10, 2022.
Online issue publication
May 17, 2023
Article Versions
- Previous version (27 April 2023).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.